These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1107224)

  • 1. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
    Sher NA; Chaparas SD; Greenberg LE; Bernard S
    Infect Immun; 1975 Dec; 12(6):1325-30. PubMed ID: 1107224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intramural injection of immunotherapeutic agents on bladder histology and systemic humoral response.
    Albert NE; Sparks FC; Lytton B
    Invest Urol; 1978 Sep; 16(2):134-9. PubMed ID: 361626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunization by Canadida albicans and non-specific immunostimulation by Corynebacterium granulosum and BCG in experimental candidiasis].
    Drouhet E; Dupont B
    C R Acad Hebd Seances Acad Sci D; 1976 Nov; 283(11 D):1385-8. PubMed ID: 825252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.
    Murphy JR
    Infect Immun; 1981 Jul; 33(1):199-211. PubMed ID: 7021424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant protection against bacterial infection in granulocytopenic mice.
    Buhles WC; Shifrine M
    J Infect Dis; 1977 Jul; 136(1):90-5. PubMed ID: 328788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium parvum: immunomodulation in local bacterial infections.
    Calhoun K; Trachtenberg L; Hart K; Polk HC
    Surgery; 1980 Jan; 87(1):52-8. PubMed ID: 6985758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.
    Hamilton JR; Overall JC; Glasgow LA
    Infect Immun; 1976 Oct; 14(4):982-9. PubMed ID: 186411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of BCG-vaccination on vaccinia virus infections in mice.
    Werner GT
    Experientia; 1979 Nov; 35(11):1514-5. PubMed ID: 389657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against herpes simplex virus infection in mice by Corynebacterium parvum.
    Kirchner H; Hirt HM; Munk K
    Infect Immun; 1977 Apr; 16(1):9-11. PubMed ID: 194841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow.
    Clark AW; Monaco AP
    Surg Forum; 1973; 24():340-3. PubMed ID: 4618660
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice.
    Carlson E
    Infect Immun; 1983 Jan; 39(1):193-7. PubMed ID: 6401691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.
    Nash EE; Peters BM; Fidel PL; Noverr MC
    Infect Immun; 2016 Jan; 84(1):90-8. PubMed ID: 26483410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G; Shaklee CL; Mak TW; Ulich TR
    Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.
    Lilly EA; Ikeh M; Nash EE; Fidel PL; Noverr MC
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1981 Jan; 42(1):67-73. PubMed ID: 7007221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B; Linta J; Hanlon J; Saffer E
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of mice against intestinal amoebiasis with BCG, Corynebacterium parvum and Listeria monocytogenes.
    Ghadirian E; Kongshavn PA
    Parasite Immunol; 1986 Nov; 8(6):663-7. PubMed ID: 2880331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagosome/lysosome fusion: a possible prerequisite for the enhancement of antibody responses in vitro by BCG, Mycobacterium leprae and Corynebacterium parvum.
    Brown CA; Brown IN; Sljivić VS
    Parasite Immunol; 1979; 1(4):309-16. PubMed ID: 399339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.